Valuation: Profarma Distribuidora de Produtos Farmacêuticos S.A.

Market Cap 867M 158M 141M 129M 118M 222M 14.82B 229M 1.56B 621M 7.91B 592M 579M 24.96B P/E 2024
6.95x
P/E 2025 9.42x
Enterprise Value 2.03B 370M 332M 303M 277M 521M 34.77B 538M 3.65B 1.46B 18.55B 1.39B 1.36B 58.56B EV / Sales 2024
0.18x
EV / Sales 2025 0.2x
Free-Float
32.86%
Yield 2024
8.86%
Yield 2025 -
07-29 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-06 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-15 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 CI
03-03 Brazil's Profarma to buy 4Bio from Raia Drogasil in 600 mln reais deal RE
11-05 Bmk, Bpl negotiate potential acquisition of Bpl shares in Brazil's Profarma RE
25-10-30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-07-31 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-04 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-18 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 CI
25-03-18 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-10-30 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-06 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-07 Profarma Distribuidora de Produtos Farmacêuticos S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
1 day-0.14%
1 week+5.05%
Current month+5.05%
1 month-20.92%
3 months+0.71%
6 months-7.22%
Current year-22.56%
1 week 6.41
Extreme 6.41
7.14
1 month 6.34
Extreme 6.34
9.59
Current year 6.11
Extreme 6.11
9.7
1 year 6.11
Extreme 6.11
9.7
3 years 3.95
Extreme 3.95
9.7
5 years 2.92
Extreme 2.92
9.7
10 years 2.87
Extreme 2.87
11.79
Manager TitleAgeSince
Chief Executive Officer 58 2010-04-20
Director of Finance/CFO 68 1992-12-31
Director TitleAgeSince
Chairman 58 2008-04-02
Director/Board Member 91 2010-04-20
Director/Board Member 62 2010-04-20
Date Insider Type Main position Quantity % Market Cap. Importance
8/8/25 Others 1 0.0000% -
12/9/24 Sell 12,200 0.0099%
12/9/24 Sell 12,400 0.0100%
Change 5-day change 1-year change 3-year change Capi.($)
-0.14%+5.05%-12.06%+78.99% 158M
-0.79%-4.48%+44.44%+127.49% 1,206B
+1.43%+1.11%+47.73%+82.08% 665B
+1.07%-1.21%+32.99%+106.31% 515B
-0.36%-3.25%+47.17%+64.58% 381B
-0.14%-1.87%+71.05%+40.63% 362B
-0.78%-0.52%+30.57%+57.98% 307B
-0.80%-0.21%+8.54%+35.56% 289B
+0.03%-1.20%+45.89%+68.76% 249B
-0.41%-2.22%+35.24%+105.68% 207B
Average -0.09%-0.85%+35.16%+76.81% 417.99B
Weighted average by Cap. -0.04%-1.96%+42.24%+88.38%

Financials

2024 2025
Net sales 10.15B 1.85B 1.66B 1.51B 1.38B 2.6B 174B 2.69B 18.24B 7.28B 92.62B 6.93B 6.78B 292B 11.45B 2.08B 1.87B 1.71B 1.56B 2.94B 196B 3.03B 20.58B 8.2B 104B 7.82B 7.65B 330B
Net income 115M 20.84M 18.69M 17.08M 15.59M 29.38M 1.96B 30.3M 206M 82.1M 1.05B 78.22M 76.54M 3.3B 119M 21.62M 19.39M 17.72M 16.18M 30.48M 2.03B 31.45M 214M 85.19M 1.08B 81.16M 79.42M 3.42B
Net Debt 1.02B 185M 166M 152M 138M 261M 17.39B 269M 1.83B 729M 9.28B 694M 679M 29.29B 1.17B 212M 190M 174M 159M 299M 19.95B 309M 2.1B 836M 10.64B 796M 779M 33.6B
Projected Income Statement - Annual - Profarma Distribuidora de Produtos Farmacêuticos S.A.
Logo Profarma Distribuidora de Produtos Farmacêuticos S.A.
Profarma Distribuidora de Produtos Farmaceuticos SA is a Brazil-based company primarily engaged in the wholesale trading of drugs. The Company's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The Company's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Employees
7,077
Date Price Change Volume
26-11-06 R$7.070 +4.74% 120,800
26-11-05 R$6.750 +3.69% 351,100
26-11-04 R$6.510 0.00% 209,200
26-11-03 R$6.510 -3.27% 217,600
26-10-30 R$6.730 +1.97% 229,900
  1. Stock Market
  2. Stocks
  3. PFRM3 Stock